These 2 Healthcare Stocks Just Declared Dividend Raises
While the pre-holiday season isn't usually a busy time for dividend raises, investors can usually expect a few companies to end the year on a high note by declaring one.
Sure enough, in the fading weeks of 2025, we've seen a smattering of payout hikes. Two of the more notable dividend raises were declared by healthcare sector mainstays Bristol Myers Squibb (NYSE: BMY) and (NYSE: ZTS). Let's take a brief, flyover look at both.
Storied pharmaceutical company Bristol Myers Squibb has a long history of paying dividends; it has done so for 94 consecutive years. It's also declared dividend raises for 17 years in a row, most lately with its mid-December declaration of an upcoming $0.63-per-share quarterly payout. That's a 1.6% increase.
Source Fool.com
Zoetis Inc. A Aktie
Die Zoetis Inc. A Aktie wird positiv bewertet: Mehrere Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Community-Kursziel von 151 € für Zoetis Inc. A deutet auf eine deutliche Steigerung um mehr als 20% gegenüber dem aktuellen Kurs von 102.26 € hin.
